Search

Your search keyword '"Sandrucci, S."' showing total 8 results
Start Over Author "Sandrucci, S." Database OAIster
8 results on '"Sandrucci, S."'

2. The ESSO core curriculum committee update on surgical oncology

Author

Hage, J.A. van der, Sandrucci, S., Audisio, R., Wyld, L., Soreide, K., Amaral, T., Bahadoer, V., Bol, K.F., Vriens, M.R., Zahl Eriksson, A.G., Hage, J.A. van der, Sandrucci, S., Audisio, R., Wyld, L., Soreide, K., Amaral, T., Bahadoer, V., Bol, K.F., Vriens, M.R., and Zahl Eriksson, A.G.

Abstract

Contains fulltext : 244708.pdf (Publisher’s version ) (Open Access)

Published
2021

3. The ESSO core curriculum committee update on surgical oncology

Author

Hage, J.A. van der, Sandrucci, S., Audisio, R., Wyld, L., Soreide, K., Amaral, T., Bahadoer, V., Bol, K.F., Vriens, M.R., Zahl Eriksson, A.G., Hage, J.A. van der, Sandrucci, S., Audisio, R., Wyld, L., Soreide, K., Amaral, T., Bahadoer, V., Bol, K.F., Vriens, M.R., and Zahl Eriksson, A.G.

Abstract

Contains fulltext : 244708.pdf (Publisher’s version ) (Open Access)

Published
2021

4. Perioperative nutrition and enhanced recovery after surgery in gastrointestinal cancer patients. A position paper by the ESSO task force in collaboration with the ERAS society (ERAS coalition)

Author

Sandrucci, S, Beets, G, Braga, M, Dejong, K, Demartines, N, Sandrucci S., Beets G., Braga M., Dejong K., Demartines N., Sandrucci, S, Beets, G, Braga, M, Dejong, K, Demartines, N, Sandrucci S., Beets G., Braga M., Dejong K., and Demartines N.

Abstract

Malnutrition in cancer patients – in both prevalence and degree – depends primarily on tumor stage and site. Preoperative malnutrition in surgical patients is a frequent problem and is associated with prolonged hospital stay, a higher rate of postoperative complications, higher re-admission rates, and a higher incidence of postoperative death. Given the focus on the cancer and its cure, nutrition is often neglected or under-evaluated, and this despite the availability of international guidelines for nutritional care in cancer patients and the evidence that nutritional deterioration negatively affects survival. Inadequate nutritional support for cancer patients should be considered ethically unacceptable; prompt nutritional support must be guaranteed to all cancer patients, as it can have many clinical and economic advantages. Patients undergoing multimodal oncological care are at particular risk of progressive nutritional decline, and it is essential to minimize the nutritional/metabolic impact of oncological treatments and to manage each surgical episode within the context of an enhanced recovery pathway. In Europe, enhanced recovery after surgery (ERAS) and routine nutritional assessment are only partially implemented because of insufficient awareness among health professionals of nutritional problems, a lack of structured collaboration between surgeons and clinical nutrition specialists, old dogmas, and the absence of dedicated resources. Collaboration between opinion leaders dedicated to ERAS from both the European Society of Surgical Oncology (ESSO) and the ERAS Society was born with the aim of promoting nutritional assessment and perioperative nutrition with and without an enhanced recovery program. The goal will be to improve awareness in the surgical oncology community and at institutional level to modify current clinical practice and identify optimal treatment options.

Published
2018

5. The management of desmoid tumours: A joint global consensus-based guideline approach for adult and paediatric patients

Author

Alman, B., Attia, S., Baumgarten, C., Benson, C., Blay, J.Y., Bonvalot, S., Breuing, J., Cardona, K., Casali, P.G., Coevorden, F. van, Colombo, C., Dei Tos, A.P., Dileo, P., Ferrari, A., Fiore, M., Frezza, A.M., Garcia, J., Gladdy, R., Gounder, M., Gronchi, A., Haas, R, Hackett, S., Haller, F., Hohenberger, P., Husson, O., Jones, R.L., Judson, I., Kasper, B., Kawai, A., Kogosov, V., Lazar, A., Maki, R., Mathes, T., Messiou, C., Navid, F., Nishida, Y., Palassini, E., Penel, N., Pollock, R., Pieper, D., Portnoy, M., Raut, C.P., Roets, E., Sandrucci, S., Sbaraglia, M., Stacchiotti, S., Thornton, K.A., Graaf, W.T.A. van der, Zande, K. van der, Houdt, W.J. van, Villalobos, V., Wagner, A.J., Wardelmann, E., Wartenberg, M., Watson, S., Weiss, A., Zafiropoulos, N., Alman, B., Attia, S., Baumgarten, C., Benson, C., Blay, J.Y., Bonvalot, S., Breuing, J., Cardona, K., Casali, P.G., Coevorden, F. van, Colombo, C., Dei Tos, A.P., Dileo, P., Ferrari, A., Fiore, M., Frezza, A.M., Garcia, J., Gladdy, R., Gounder, M., Gronchi, A., Haas, R, Hackett, S., Haller, F., Hohenberger, P., Husson, O., Jones, R.L., Judson, I., Kasper, B., Kawai, A., Kogosov, V., Lazar, A., Maki, R., Mathes, T., Messiou, C., Navid, F., Nishida, Y., Palassini, E., Penel, N., Pollock, R., Pieper, D., Portnoy, M., Raut, C.P., Roets, E., Sandrucci, S., Sbaraglia, M., Stacchiotti, S., Thornton, K.A., Graaf, W.T.A. van der, Zande, K. van der, Houdt, W.J. van, Villalobos, V., Wagner, A.J., Wardelmann, E., Wartenberg, M., Watson, S., Weiss, A., and Zafiropoulos, N.

Abstract

Contains fulltext : 217698.pdf (Publisher’s version ) (Open Access)

Published
2020

6. The management of desmoid tumours: A joint global consensus-based guideline approach for adult and paediatric patients

Author

Alman, B., Attia, S., Baumgarten, C., Benson, C., Blay, J.Y., Bonvalot, S., Breuing, J., Cardona, K., Casali, P.G., Coevorden, F. van, Colombo, C., Dei Tos, A.P., Dileo, P., Ferrari, A., Fiore, M., Frezza, A.M., Garcia, J., Gladdy, R., Gounder, M., Gronchi, A., Haas, R, Hackett, S., Haller, F., Hohenberger, P., Husson, O., Jones, R.L., Judson, I., Kasper, B., Kawai, A., Kogosov, V., Lazar, A., Maki, R., Mathes, T., Messiou, C., Navid, F., Nishida, Y., Palassini, E., Penel, N., Pollock, R., Pieper, D., Portnoy, M., Raut, C.P., Roets, E., Sandrucci, S., Sbaraglia, M., Stacchiotti, S., Thornton, K.A., Graaf, W.T.A. van der, Zande, K. van der, Houdt, W.J. van, Villalobos, V., Wagner, A.J., Wardelmann, E., Wartenberg, M., Watson, S., Weiss, A., Zafiropoulos, N., Alman, B., Attia, S., Baumgarten, C., Benson, C., Blay, J.Y., Bonvalot, S., Breuing, J., Cardona, K., Casali, P.G., Coevorden, F. van, Colombo, C., Dei Tos, A.P., Dileo, P., Ferrari, A., Fiore, M., Frezza, A.M., Garcia, J., Gladdy, R., Gounder, M., Gronchi, A., Haas, R, Hackett, S., Haller, F., Hohenberger, P., Husson, O., Jones, R.L., Judson, I., Kasper, B., Kawai, A., Kogosov, V., Lazar, A., Maki, R., Mathes, T., Messiou, C., Navid, F., Nishida, Y., Palassini, E., Penel, N., Pollock, R., Pieper, D., Portnoy, M., Raut, C.P., Roets, E., Sandrucci, S., Sbaraglia, M., Stacchiotti, S., Thornton, K.A., Graaf, W.T.A. van der, Zande, K. van der, Houdt, W.J. van, Villalobos, V., Wagner, A.J., Wardelmann, E., Wartenberg, M., Watson, S., Weiss, A., and Zafiropoulos, N.

Abstract

Contains fulltext : 217698.pdf (Publisher’s version ) (Open Access)

Published
2020

8. Rare Cancers Europe (RCE) methodological recommendations for clinical studies in rare cancers: A European consensus position paper

Author

Casali, P.G. (Paolo), Bruzzi, P. (P.), Bogaerts, J. (Jan), Blay, J.Y. (Jean Yves), Aapro, M. (Matti), Adamous, A., Berruti, A. (Alfredo), Bressington, J., Bruzzi, B., Capocaccia, R. (Riccardo), Cardoso, F. (Fatima), Celis, J.E., Cervantes, A. (Andres), Ciardiello, F., Claussen, C., Coleman, M., Comis, S., Craine, S., De Boltz, D., De Lorenzo, F., Dei Tos, A.P. (Angelo), Gatta, G. (Gemma), Geissler, J. (Jan), Giuliani, R., Grande, E. (Enrico), Gronchi, A. (Alessandro), Jezdic, S., Jonsson, B., Jost, L., Keulen, H., Lacombe, D. (Denis), Lamory, G., Le Cam, Y., Leto di Priolo, S., Licitra, L., Macchia, F., Margulies, A., Marreaud, S. (Sandrine), McVie, G., Narbutas, S., Oliver, K., Pavlidis, N., Pelouchova, J., Pentheroudakis, G., Piccart, M.J. (Martine), Pierotti, M. (Marco Alessandro), Pravettoni, G., Redmond, K., Riegman, P.H.J. (Peter), Ruffilli, M.P., Ryner, D., Sandrucci, S., Seymour, M., Torri, V. (Valter), Trama, A., Belle, S. (S.) van, Vassal, G., Wartenberg, M., Watts, C., Wilson, A., Yared, W., Casali, P.G. (Paolo), Bruzzi, P. (P.), Bogaerts, J. (Jan), Blay, J.Y. (Jean Yves), Aapro, M. (Matti), Adamous, A., Berruti, A. (Alfredo), Bressington, J., Bruzzi, B., Capocaccia, R. (Riccardo), Cardoso, F. (Fatima), Celis, J.E., Cervantes, A. (Andres), Ciardiello, F., Claussen, C., Coleman, M., Comis, S., Craine, S., De Boltz, D., De Lorenzo, F., Dei Tos, A.P. (Angelo), Gatta, G. (Gemma), Geissler, J. (Jan), Giuliani, R., Grande, E. (Enrico), Gronchi, A. (Alessandro), Jezdic, S., Jonsson, B., Jost, L., Keulen, H., Lacombe, D. (Denis), Lamory, G., Le Cam, Y., Leto di Priolo, S., Licitra, L., Macchia, F., Margulies, A., Marreaud, S. (Sandrine), McVie, G., Narbutas, S., Oliver, K., Pavlidis, N., Pelouchova, J., Pentheroudakis, G., Piccart, M.J. (Martine), Pierotti, M. (Marco Alessandro), Pravettoni, G., Redmond, K., Riegman, P.H.J. (Peter), Ruffilli, M.P., Ryner, D., Sandrucci, S., Seymour, M., Torri, V. (Valter), Trama, A., Belle, S. (S.) van, Vassal, G., Wartenberg, M., Watts, C., Wilson, A., and Yared, W.

Abstract

While they account for one-fifth of new cancer cases, rare cancers are difficult to study. A higher than average degree of uncertainty should be accommodated for clinical as well as for population-based decision making. Rules of rational decision making in conditions of uncertainty should be rigorously followed and would need widely informative clinical trials. In principle, any piece of new evidence would need to be exploited in rare cancers. Methodologies to explicitly weigh and combine all the available evidence should be refined, and the Bayesian logic can be instrumental to this end. Likewise, Bayesian-design trials may help optimize the low number of patients liable to be enrolled in clinical studies on rare cancers, as well as adaptive trials in general, with their inherent potential of flexibility when properly applied. While clinical studies are the mainstay to test hypotheses, the potential of electronic patient records should be exploited to generate new hypotheses, to create external controls for future studies (when internal controls are unpractical), to study effectiveness of new treatments in real conditions. Framework study protocols in specific rare cancers to stepwisely test sets of new agents, as from the early post-phase I dev

Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results